Ospedale Cannizzaro
In research, Ospedale Cannizzaro stands highest in Medicine (#3,028 of 10,443 worldwide) and Health Sciences (#4,139 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Pulmonary and Respiratory Medicine and Surgery — Pulmonary and Respiratory Medicine is 8.5× its share of world research.
- World rank, 2022–2025
- #10,631 of 28,054 · #14,029 all time
- Rank in Italy
- #300 of 618
- Research works
- 868 ▲ 14% vs 2013–17
- Citations
- 15k 16.9 per fractional work
- Top-10% rate
- 23.2% record average 16.5%
- Open access
- 44% world 28%
What is Ospedale Cannizzaro known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #3,028 of 10,443 | 23.6% | 150 | #5553 | |
| Health SciencesDomain | #4,139 of 11,982 | 23.1% | 156 | #7314 |
Each strip is that field’s whole ranked pool, with the notch where Ospedale Cannizzaro sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Ospedale Cannizzaro specialise in?
Where its research is concentrated relative to its size: Pulmonary and Respiratory Medicine takes 8.5× the share of its output that it takes of world research.
- Pulmonary and Respiratory MedicineSubfield · 24.5 works8.5×
- SurgerySubfield · 26.5 works6.1×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.2×. Every wedge is a field page.
- Medicine 4.2×
- Neuroscience 1.5×
- Immunology and Microbiology 1.4×
- Veterinary 1.3×
- Biochemistry, Genetics and Molecular Biology 1.1×
- Health Professions 0.9×
- Dentistry 0.8×
- Nursing 0.7×
- Pharmacology, Toxicology and Pharmaceutics 0.5×
- Physics and Astronomy 0.5×
- Psychology 0.2×
- Computer Science 0.1×
- Economics, Econometrics and Finance 0.1×
- Engineering 0.1×
- Social Sciences 0.1×
- Decision Sciences 0.1×
- Agricultural and Biological Sciences 0.1×
- Earth and Planetary Sciences 0.1×
- Materials Science 0.1×
- Energy 0.1×
- Environmental Science 0.1×
- Business, Management and Accounting 0.0×
- Chemistry 0.0×
- Mathematics 0.0×
Who are the top researchers at Ospedale Cannizzaro?
Ranked on the composite score, Filippo Fraggetta, Giuseppe Emmanuele Umana and Paolo Scollo lead among researchers whose main affiliation is Ospedale Cannizzaro.
- 1 Filippo Fraggetta Italy · #419,493 worldwide 58 citations · 26 works
- 2 Giuseppe Emmanuele Umana Italy · #615,295 worldwide 16 citations · 21 works
- 3 Paolo Scollo Italy · #685,019 worldwide 39 citations · 23 works
- 4 Giuseppe Luigi Banna Italy · #723,977 worldwide 82 citations · 44 works
- 5 Pietro Pepe Italy · #941,732 worldwide 35 citations · 25 works
- 6 Antonio Granata Italy · #1,008,725 worldwide 65 citations · 89 works
- 7 Giuseppe Catanuto Italy · #1,013,441 worldwide 20 citations · 19 works
- 8 Vita Di Stefano Italy · #1,050,335 worldwide 73 citations · 61 works
- 9 Massimo Ippolito Italy · #1,119,239 worldwide 22 citations · 19 works
- 10 Giuseppa Scandurra Italy · #1,229,785 worldwide 23 citations · 22 works
Which keywords describe research at Ospedale Cannizzaro?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Immunotherapy, Genetic Mutations, Prostate Cancer, Clinical Trials, Clinical Guidelines, Surgical Management and Radiation Therapy.
- Survival Analysis
- Clinical Outcomes
- Molecular Classification
- Robotic Surgery
- Metastatic Prostate Cancer
- Hormone Therapy
- Genomic Analysis
- Androgen Suppression
- Clinical Practice Guidelines
- MRI Imaging
- Complications
- Radiosurgery
- Genetic Variants
- Radiotherapy
- Radiation Therapy
- Surgical Management
- Clinical Guidelines
- Inflammation
- Prostate Cancer
- Immunotherapy
- Epidemiology
- Genetic Mutations
- Clinical Trials
- Treatment
- Biomarkers
- Prognostic Factors
- Quality of Life
- Chemotherapy
- Risk Factors
- Cardiovascular Disease
- Survival Rates
- Biopsy
- Screening
- Gleason Grading
- Genomic Profiling
- Androgen Receptor
- Rehabilitation
- Biomechanics
- Surgical Treatment
- Targeted Therapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology22▲ 3.0×78 topics
- Immunotherapy13▲ 10×15 topics
- Genetic Mutations12▲ 14×18 topics
- Prostate Cancer11▲ 45×3 topics
- Clinical Trials10▲ 8.4×15 topics
- Inflammation10▲ 2.6×41 topics
- Treatment10▲ 4.3×32 topics
- Clinical Guidelines9▲ 16×7 topics
- Biomarkers8▲ 6.5×9 topics
- Surgical Management8▲ 11×17 topics
- Prognostic Factors8▲ 9.8×13 topics
- Radiation Therapy8▲ 33×6 topics
- Quality of Life8▲ 2.9×21 topics
- Radiotherapy8▲ 11×12 topics
- Chemotherapy7▲ 5.7×21 topics
- Genetic Variants7▲ 22×5 topics
- Risk Factors7▲ 3.2×21 topics
- Radiosurgery7▲ 39×4 topics
- Cardiovascular Disease6▲ 3.1×22 topics
- Complications6▲ 6.9×14 topics
- Survival Rates6▲ 36×2 topics
- MRI Imaging6▲ 41×4 topics
- Biopsy6▲ 55×2 topics
- Clinical Practice Guidelines6▲ 6.2×14 topics
- Screening6▲ 34×3 topics
- Androgen Suppression6▲ 80×1 topic
- Gleason Grading6▲ 80×1 topic
- Genomic Analysis5▲ 12×4 topics
- Genomic Profiling5▲ 27×2 topics
- Hormone Therapy5▲ 33×3 topics
- Androgen Receptor5▲ 36×1 topic
- Metastatic Prostate Cancer5▲ 65×1 topic
- Rehabilitation4▲ 6.1×8 topics
- Robotic Surgery4▲ 17×5 topics
- Biomechanics4▲ 7.8×5 topics
- Molecular Classification4▲ 16×4 topics
- Surgical Treatment4▲ 11×6 topics
- Clinical Outcomes4▲ 9.9×6 topics
- Targeted Therapy4▲ 9.3×5 topics
- Survival Analysis4▲ 7.5×6 topics
Which research topics does Ospedale Cannizzaro publish most on?
By volume in 2022–2025: Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Meningioma and schwannoma management and Glioma Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 6 works
- 2 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 5 works
- 3 Meningioma and schwannoma management Epidemiology 3 works
- 4 Glioma Diagnosis and Treatment Genetics 3 works
- 5 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 2 works
- 6 Brain Metastases and Treatment Pulmonary and Respiratory Medicine 2 works
- 7 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 2 works
- 8 Spinal Fractures and Fixation Techniques Surgery 2 works
- 9 Neurofibromatosis and Schwannoma Cases Neurology 2 works
- 10 Ovarian cancer diagnosis and treatment Reproductive Medicine 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Ospedale Cannizzaro's research output changed?
Output in 2018–2022 was 14% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Catania
- University of Catania
- Istituto di Chimica Biomolecolare
- Institute for Microelectronics and Microsystems
- Policlinico Universitario di Catania
- Istituto Nazionale di Fisica Nucleare, Sezione di Catania
- Istituto Nazionale di Fisica Nucleare, Laboratori Nazionali del Sud
- Osservatorio Astrofisico di Catania
- Ospedale Garibaldi
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.